Skip to main content
Equibles

OPPENHEIMER ASSET MANAGEMENT INC.

Position in GMAB — Genmab A/S

CIK 1269119 NEW YORK, NY
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$12,290,791
+$15,852 QoQ
Shares Held
447,426
-2.2% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#32
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $60,234,083 across 32 Biotechnology names. GMAB ranks #1 (20.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GMAB
Genmab A/S
This page 		447,426 $12,290,791
2 ONC
BeOne Medicines Ltd.
 35,781 $10,196,511
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 17,931 $8,906,863
4 ALNY
Alnylam Pharmaceuticals, Inc.
 19,608 $5,902,596
5 TECH
BIO-TECHNE Corp
 39,080 $2,760,999
6 HALO
Halozyme Therapeutics, Inc.
 29,098 $2,277,499
7 JAZZ
Jazz Pharmaceuticals plc
 8,356 $2,013,545
8 INSM
INSMED Inc
 16,061 $1,712,423

All Filings in GMAB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,290,791 447,426
2026-03-31 $12,274,939 457,508
2025-12-31 $11,234,484 364,756
2025-09-30 $9,687,487 315,862
2025-06-30 $5,259,023 254,551
2025-03-31 $4,884,583 249,468
2024-12-31 $4,322,322 207,107
2024-09-30 $5,662,083 232,243
2024-06-30 $5,480,299 218,078
2024-03-31 $5,165,515 172,702
2023-12-31 $5,847,511 183,653
2023-09-30 $6,819,842 193,361
2023-06-30 $7,229,881 190,210
2023-03-31 $4,169,722 110,427
2022-12-31 $4,660,613 109,972
2022-09-30 $4,360,844 135,725
2022-06-30 $4,551,327 140,084
2022-03-31 $4,951,449 136,856
2021-12-31 $6,414,889 162,156
2021-09-30 $7,378,262 168,839
2021-06-30 $7,511,943 183,981
2021-03-31 $5,810,285 176,981
2020-12-31 $6,671,410 164,078
2020-09-30 $5,813,446 158,794
2020-06-30 $6,420,357 189,447
2020-03-31 $5,184,598 244,672